ATOPIC DERMATITIS (AD)
Clinical trials for ATOPIC DERMATITIS (AD) explained in plain language.
Never miss a new study
Get alerted when new ATOPIC DERMATITIS (AD) trials appear
Sign up with your email to follow new studies for ATOPIC DERMATITIS (AD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eczema pill shows promise in major trial
Disease control ENROLLING_BY_INVITATIONThis study tests an experimental tablet called QY201 for adults with moderate to severe atopic dermatitis (eczema). About 460 participants will take either QY201 or a placebo daily for 16 weeks. The goal is to see if the drug can significantly clear skin and reduce itch, with a f…
Matched conditions: ATOPIC DERMATITIS (AD)
Phase: PHASE3 • Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. • Aim: Disease control
Last updated May 05, 2026 11:54 UTC
-
New itch drug enters first human safety tests
Symptom relief OngoingThis early-stage study tests a new drug called ATTO1310 in healthy adults, people with eczema, and people with long-term itching. The main goal is to check for side effects and see how the drug moves through the body. About 108 participants will receive either the drug or a place…
Matched conditions: ATOPIC DERMATITIS (AD)
Phase: PHASE1 • Sponsor: Attovia Therapeutics Inc • Aim: Symptom relief
Last updated May 26, 2026 04:59 UTC
-
New pill shows promise for severe eczema sufferers
Symptom relief OngoingThis study tests a new tablet called HSK44459 in 150 adults with moderate-to-severe atopic dermatitis (eczema). Participants take the tablet for 12 weeks to see if it reduces skin redness, itching, and rash. The goal is to find a safe and effective way to ease symptoms.
Matched conditions: ATOPIC DERMATITIS (AD)
Phase: PHASE2 • Sponsor: Xizang Haisco Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated May 26, 2026 04:38 UTC
-
Could a simple cholesterol cream soothe eczema?
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a cream containing 2% cholesterol can help repair the skin barrier and ease symptoms in children aged 7 to 17 with mild to moderate eczema. About 30 participants will apply the cream or a placebo twice daily for 12 weeks. Researchers will measure skin moi…
Matched conditions: ATOPIC DERMATITIS (AD)
Phase: NA • Sponsor: Institute of Dermatology, Thailand • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC
-
New eczema drug candidate tested in healthy people for first time
Knowledge-focused OngoingThis early-stage study tests a new medicine called GB-7624 in 40 healthy adults to see if it is safe and how the body processes it. The study has two parts: one group gets a single dose, and another gets two doses over two weeks. This research is a first step toward possibly trea…
Matched conditions: ATOPIC DERMATITIS (AD)
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Knowledge-focused
Last updated May 18, 2026 12:00 UTC